Influence of green tea ingestion on the pharmacokinetics of lisinopril in healthy volunteers

Influence of green tea ingestion on the pharmacokinetics of lisinopril in healthy volunteers - Green tea-lisinopril study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030894

Enrollment

Registered

2018-01-20

Start date

2017-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Subjects receive an oral dose of lisinopril (Zestril 10mg tablet, Astrazeneca) with 200 ml of water after overnight fasting. Blood sampling and measurements of pulse rate and blood pressure are perfor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To be healthy without receiving medicines regularly

Exclusion criteria

Exclusion criteria: Smoker

Design outcomes

Primary

Measure	Time frame
Area under the plasma concentration-time curve (AUC) of lisinopril	—

Secondary

Measure	Time frame
Urinary excretion of lisinopril	—

Countries

Japan

Contacts

Public ContactShingen Misaka

Fukushima Medical University Department of Pharmacology

misaka@fmu.ac.jp024-547-1156

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026